PGI Chandigarh starts plasma therapy trial for COVID-19 patients
May 05, 2020
Chandigarh (Punjab) [India], May 5 : PGI Chandigarh has been approved as one of the national centres by the Indian Council of Medical Research (ICMR) to conduct the trial of convalescent plasma therapy in patients with serious COVID-19 infection.